January 10, 2024 By Jim Hammerand How alcohol could make renal denervation for hypertension faster and simpler
December 21, 2023 By Jim Hammerand Recor Medical CEO Lara Barghout on leadership lessons and what she looks for when hiring
December 8, 2023 By Jim Hammerand Medtronic execs: renal denervation for AFib could be on the horizon
October 24, 2023 By Sean Whooley Medtronic selects location for renal denervation tech manufacturing — if approved by FDA
August 25, 2023 By Jim Hammerand Engineers wanted: ReCor Medical’s hiring as its RDN system awaits FDA approval
August 24, 2023 By Jim Hammerand After Medtronic’s latest setback, what’s next for Symplicity Spyral RDN?
August 23, 2023 By Jim Hammerand Risks of Medtronic Symplicity Spyral renal denervation (RDN) outweigh benefits: FDA review panel
November 8, 2022 By Jim Hammerand What’s next for Medtronic RDN after Symplicity Spyral trial ‘surprise’?
April 4, 2022 By Jim Hammerand Medtronic releases new renal denervation results, closes trial enrollment
March 21, 2022 By Chris Newmarker Some analysts are upbeat about Medtronic’s renal denervation prospects
November 12, 2021 By Jim Hammerand What is renal denervation? Medtronic Coronary and RDN President Jason Weidman explains
